对“生物反应器：骨骼肌修复和替代工程的再生方法”的更正

IF 4.4 Q2 ENGINEERING, BIOMEDICAL

Advanced Nanobiomed Research Pub Date : 2025-05-27 DOI:10.1002/anbr.202500111

{"title":"对“生物反应器：骨骼肌修复和替代工程的再生方法”的更正","authors":"","doi":"10.1002/anbr.202500111","DOIUrl":null,"url":null,"abstract":"Williamson, A., Khoshmanesh, K., Pirogova, E., Yang, P., Snow, F., Williams, R., Quigley, A. and Kapsa, R.M.I. (2024), Bioreactors: A Regenerative Approach to Skeletal Muscle Engineering for Repair and Replacement. Adv. NanoBiomed Res., 4: 2400030. https://doi.org/10.1002/anbr.202400030Correction to “Table 1. Myogenic Markers”Table 1, in paragraph 7 of the “Introduction” section, the text “Initiates differentiation of myoblasts to stem cells” was incorrect for myogenic factors Myf5 and MyoD. This should have read: “Initiates differentiation of stem cells to myoblasts.”We apologize for this error.","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"5 9","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://advanced.onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500111","citationCount":"0","resultStr":"{\"title\":\"Correction to “Bioreactors: A Regenerative Approach to Skeletal Muscle Engineering for Repair and Replacement”\",\"authors\":\"\",\"doi\":\"10.1002/anbr.202500111\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Williamson, A., Khoshmanesh, K., Pirogova, E., Yang, P., Snow, F., Williams, R., Quigley, A. and Kapsa, R.M.I. (2024), Bioreactors: A Regenerative Approach to Skeletal Muscle Engineering for Repair and Replacement. Adv. NanoBiomed Res., 4: 2400030. https://doi.org/10.1002/anbr.202400030Correction to “Table 1. Myogenic Markers”Table 1, in paragraph 7 of the “Introduction” section, the text “Initiates differentiation of myoblasts to stem cells” was incorrect for myogenic factors Myf5 and MyoD. This should have read: “Initiates differentiation of stem cells to myoblasts.”We apologize for this error.\",\"PeriodicalId\":29975,\"journal\":{\"name\":\"Advanced Nanobiomed Research\",\"volume\":\"5 9\",\"pages\":\"\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://advanced.onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500111\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Nanobiomed Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://advanced.onlinelibrary.wiley.com/doi/10.1002/anbr.202500111\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://advanced.onlinelibrary.wiley.com/doi/10.1002/anbr.202500111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 0

摘要

Williamson， A., Khoshmanesh， K., Pirogova， E., Yang， P., Snow， F., Williams， R., Quigley， A.和Kapsa， R.M.I.(2024)，生物反应器：骨骼肌修复和替代工程的再生方法。纳米生物学报，4(4):2400030。https://doi.org/10.1002/anbr.202400030Correction到表1。表1，“引言”部分第7段中，文本“initiate differentiation of myoblasts to stem cells”对于Myf5和MyoD的成肌因子是不正确的。这应该是：“启动干细胞向成肌细胞的分化。”我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction to “Bioreactors: A Regenerative Approach to Skeletal Muscle Engineering for Repair and Replacement”

查看原文本刊更多论文

Correction to “Bioreactors: A Regenerative Approach to Skeletal Muscle Engineering for Repair and Replacement”

Williamson, A., Khoshmanesh, K., Pirogova, E., Yang, P., Snow, F., Williams, R., Quigley, A. and Kapsa, R.M.I. (2024), Bioreactors: A Regenerative Approach to Skeletal Muscle Engineering for Repair and Replacement. Adv. NanoBiomed Res., 4: 2400030. https://doi.org/10.1002/anbr.202400030

Correction to “Table 1. Myogenic Markers”

Table 1, in paragraph 7 of the “Introduction” section, the text “Initiates differentiation of myoblasts to stem cells” was incorrect for myogenic factors Myf5 and MyoD. This should have read: “Initiates differentiation of stem cells to myoblasts.”

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-

CiteScore

5.00

自引率

5.90%

发文量

审稿时长

21 weeks

期刊介绍： Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.